NL302932A - - Google Patents

Info

Publication number
NL302932A
NL302932A NL302932DA NL302932A NL 302932 A NL302932 A NL 302932A NL 302932D A NL302932D A NL 302932DA NL 302932 A NL302932 A NL 302932A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL302932A publication Critical patent/NL302932A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL302932D 1962-12-31 NL302932A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB49140/62A GB1027746A (en) 1962-12-31 1962-12-31 17-amino-androstane and -androstene derivatives
GB220063 1963-01-17

Publications (1)

Publication Number Publication Date
NL302932A true NL302932A (ja)

Family

ID=26237361

Family Applications (1)

Application Number Title Priority Date Filing Date
NL302932D NL302932A (ja) 1962-12-31

Country Status (5)

Country Link
BE (1) BE642020A (ja)
ES (1) ES294887A1 (ja)
FR (2) FR1432523A (ja)
GB (1) GB1027746A (ja)
NL (1) NL302932A (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075464A (en) * 1987-04-22 1991-12-24 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropylamino)androstene derivatives
NZ224288A (en) * 1987-04-22 1989-12-21 Merrell Dow Pharma 17b-(cyclopropylamino)androst-5-en-3b-ol and related compounds and methods using these for treatment of non-humans
US4954488A (en) * 1989-06-14 1990-09-04 Merrell Dow Pharmaceuticals Inc. Method of treating hyperaldosteronism using 17β-cyclopropylaminoandrostene derivatives
US4966898A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors

Also Published As

Publication number Publication date
GB1027746A (en) 1966-04-27
FR1432523A (fr) 1966-03-25
ES294887A1 (es) 1964-04-16
FR3159M (fr) 1965-03-01
BE642020A (ja) 1964-06-30

Similar Documents

Publication Publication Date Title
BE616548R (ja)
BE634336A (ja)
BE613335A (ja)
BE380301A (ja)
BE489310A (ja)
BE538252A (ja)
BE538831A (ja)
BE541929A (ja)
BE553896A (ja)
BE559145A (ja)
AU269855A (ja)
BE586180A (ja)
BE592434A (ja)
BE599783A (ja)
BE604335A (ja)
BE608197A (ja)
BE609543A (ja)
BE612190A (ja)
BE612311A (ja)
BE612464A (ja)
BE612847A (ja)
BE612926A (ja)
BE613108A (ja)
BE613190A (ja)
BE613298A (ja)